{
  "slug": "bramante-biologics",
  "name": "Bramante Biologics",
  "yc_id": 30516,
  "batch": "Spring 2025",
  "website": "https://www.bramantebio.com",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:38:38.750440",
    "website": "https://www.bramantebio.com",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 1894.45,
      "final_url": "https://www.bramantebio.com/",
      "redirected": true,
      "checked_at": "2025-10-17T01:38:40.644907"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "bramantebio.com",
      "registrar": "GoDaddy.com, LLC",
      "creation_date": "2025-05-14T20:05:52",
      "expiration_date": "2028-05-14T20:05:52",
      "domain_age_days": 155,
      "domain_age_years": 0.4,
      "name_servers": [
        "NS41.DOMAINCONTROL.COM",
        "NS42.DOMAINCONTROL.COM"
      ]
    },
    "social_links": {
      "twitter": null,
      "linkedin": null,
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": true,
      "content_security_policy": false,
      "x_frame_options": false,
      "x_content_type_options": false,
      "x_xss_protection": false,
      "referrer_policy": false,
      "security_score": 16,
      "server": "Vercel"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:39:23.964798",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0",
    "model_used": "google/gemini-2.0-flash-001",
    "enriched_at": "2025-10-17T12:41:23.378881",
    "status": "success",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "mature",
      "key_trends": [
        "Reshoring of pharmaceutical manufacturing",
        "Increased demand for drug manufacturing speed and agility",
        "Focus on supply chain security and resilience"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Potentially proprietary manufacturing processes and speed.",
      "differentiation": "Faster drug manufacturing in the USA.",
      "competitive_advantages": [
        "Location (USA)",
        "Speed of manufacturing"
      ],
      "competitive_vulnerabilities": [
        "Reliance on regulatory approvals",
        "Competition from established manufacturers with economies of scale"
      ]
    },
    "business_model": {
      "revenue_model": "Manufacturing/Service",
      "scalability": "medium",
      "capital_intensity": "high"
    },
    "growth_assessment": {
      "growth_stage": "seed",
      "growth_indicators": [
        "Partnerships with pharmaceutical companies",
        "Successful regulatory approvals"
      ],
      "growth_bottlenecks": [
        "Securing funding for expansion",
        "Navigating regulatory hurdles"
      ]
    },
    "risk_analysis": {
      "market_risk": "low",
      "technology_risk": "medium",
      "execution_risk": "high",
      "overall_risk_score": 6,
      "key_risks": [
        "Regulatory delays",
        "Manufacturing scalability challenges",
        "Competition from established players"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Strong tailwinds from reshoring trend",
        "Addresses a critical need for faster drug manufacturing",
        "Potential for high margins if manufacturing speed is significantly improved"
      ],
      "concerns": [
        "High capital expenditure requirements",
        "Dependence on regulatory approvals"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Contract manufacturing organizations (CMOs)",
        "Emerging biotech manufacturing startups"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Secure strategic partnerships with pharmaceutical companies",
        "Focus on obtaining necessary regulatory approvals",
        "Demonstrate scalability of manufacturing process"
      ],
      "expansion_opportunities": [
        "Expand manufacturing capabilities to include a wider range of drugs",
        "Offer specialized manufacturing services for niche markets"
      ]
    },
    "tokens_used": {
      "prompt": 615,
      "completion": 595,
      "total": 1210,
      "estimated_cost": 0.000225
    }
  },
  "phase8_complete": true
}